Code | Display | Comments |
---|
1-8 | Acyclovir [Susceptibility] | |
10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer | |
100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | |
1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit | |
10000-8 | R wave duration in lead AVR | | |
100002-5 | Specimen care is maintained | | |
100003-3 | Team communication is maintained throughout care | | |
100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | | |
100005-8 | Demonstrates knowledge of nutritional management related to the procedure | | |
100006-6 | Demonstrates knowledge of medication management | | |
100007-4 | Demonstrates knowledge of pain management | | |
100008-2 | Demonstrates knowledge of wound management | | |
100009-0 | Demonstrates knowledge of the procedure and expected results | | |
10001-6 | R wave duration in lead I | | |
100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation | | |
100011-6 | No injury related to an electrical source | | |
100012-4 | Participates in decisions affecting the patient's plan of care | | |
100013-2 | Participates in the discharge process | | |
100014-0 | Psychosocial health is maintained at or improved from baseline | | |
100015-7 | No injury related to positioning due to care or procedure | | |
100016-5 | No injury related to a laser source | | |
100017-3 | Perioperative nursing data set outcomes panel [PNDS] | | |
100018-1 | Hospice care Note | | |
100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
10002-4 | R wave duration in lead II | | |
100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | |
10003-2 | R wave duration in lead III | | |
100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] | | |
100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | | |
100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | | |
100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | | |
100034-8 | Provider of automated external defibrillator use | | |
100035-5 | Exam finding location of Chest | | |
100036-3 | Exam finding location of Lung | | |
100037-1 | Patient contact disposition EMS unit | | |
100038-9 | Patient evaluation disposition EMS unit | | |
100039-7 | Crew disposition for patient care EMS unit | | |
10004-0 | R wave duration in lead V1 | | |
100040-5 | Patient transport disposition EMS unit | | |
100041-3 | Aminoglycoside [Susceptibility] | |
100042-1 | Atovaquone [Susceptibility] | |
100043-9 | Azithromycin+Ethambutol [Susceptibility] | |
100044-7 | Cefcapene [Susceptibility] | |
100045-4 | Cefozopran [Susceptibility] | |
100046-2 | Cefquinome [Susceptibility] | |
100047-0 | Cefteram [Susceptibility] | |
100048-8 | Clarithromycin+Ethambutol [Susceptibility] | |
100049-6 | Eravacycline [Susceptibility] | |
10005-7 | R wave duration in lead V2 | | |
100050-4 | Erythromycin+Ethambutol [Susceptibility] | |
100051-2 | Ethambutol+rifAMPin [Susceptibility] | |
100052-0 | Flomoxef [Susceptibility] | |
100053-8 | Fluoroquinolone [Susceptibility] | |
100054-6 | Gamithromycin [Susceptibility] | |
100055-3 | Optochin [Susceptibility] | |
100056-1 | Panipenem [Susceptibility] | |
100057-9 | Prothionamide [Susceptibility] | |
100058-7 | Prulifloxacin [Susceptibility] | |
100059-5 | Rifapentine [Susceptibility] | |
10006-5 | R wave duration in lead V3 | | |
100060-3 | Tildipirosin [Susceptibility] | |
100061-1 | Tosufloxacin [Susceptibility] | |
100062-9 | Standard Dermatology Outcome Measures panel | | |
100063-7 | Primary skin concern | | |
100064-5 | Itch severity Reporting Period - Reported | | |
100065-2 | Satisfied with treatment | | |
100066-0 | Specular microscopy panel | | |
100067-8 | Eye Image magnification | | |
100068-6 | Right eye Fixation point [Angle] | | |
100069-4 | Left eye Fixation point [Angle] | | |
10007-3 | R wave duration in lead V4 | | |
100070-2 | Right cornea Cell density | | |
100071-0 | Left cornea Cell density | | |
100072-8 | Right cornea Coefficient of variation | | |
100073-6 | Left cornea Coefficient of variation | | |
100074-4 | Right cornea Hexagonality | | |
100075-1 | Left cornea Hexagonality | | |
100076-9 | Right cornea Endothelial cells counted | | |
100077-7 | Left cornea Endothelial cells counted | | |
100078-5 | Right cornea Endothelial cell area.min | | |
100079-3 | Left cornea Endothelial cell area.min | | |
10008-1 | R wave duration in lead V5 | | |
100080-1 | Right cornea Endothelial cell area.max | | |
100081-9 | Left cornea Endothelial cell area.max | | |
100082-7 | Right cornea Endothelial cell area.mean | | |
100083-5 | Left cornea Endothelial cell area.mean | | |
100084-3 | Right cornea Cell area.standard deviation | | |
100085-0 | Left cornea Cell area.standard deviation | | |
100086-8 | Right cornea Type of Analysis method by Specular microscopy | | |
100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | |
100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot | |
100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | |
10009-9 | R wave duration in lead V6 | | |
100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | |
100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | |
100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | |
100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | |
100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | |
100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | |
100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | |
100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | |
100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | |
1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor | |
10010-7 | R' wave amplitude in lead AVF | | |
100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | |
100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | |
100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | |
100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | |
100105-6 | Filaria IgG and IgM panel - Serum | |
100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay | |
100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | |
100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | |
100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot | |
10011-5 | R' wave amplitude in lead AVL | | |
100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | |
100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | |
100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot | |
100113-0 | Helicobacter pylori Ab panel - Serum | |
100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | |
100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | |
100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | |
100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | |
100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | |
100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | |
10012-3 | R' wave amplitude in lead AVR | | |
100120-5 | Chlamydia trachomatis Ab panel - Serum | |
100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | |
100122-1 | Chlamydophila pneumoniae Ab panel - Serum | |
100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | |
100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | |
100125-4 | Chlamydophila psittaci Ab panel - Serum | |
100126-2 | Bordetella pertussis Ab.IgG panel - Serum | |
100127-0 | Campylobacter sp Ab panel - Serum | |
100128-8 | Cryptococcus sp Ag panel - Serum | |
100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | |
10013-1 | R' wave amplitude in lead I | | |
100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | |
100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | |
100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | |
100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | |
100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | |
100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | |
100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | |
100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | |
100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | |
100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | |
10014-9 | R' wave amplitude in lead II | | |
100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | |
100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | |
100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | |
100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | |
100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | |
100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | |
100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | |
100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | |
100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot | |
100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | |
10015-6 | R' wave amplitude in lead III | | |
100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | |
100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | |
100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
100154-4 | Specimen collection supervision level | |
100155-1 | Left cornea Type of Analysis method by Specular microscopy | | |
100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | |
100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | |
100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration | |
100159-3 | Knee Society Score pre-op panel [Knee Society Score] | | |
10016-4 | R' wave amplitude in lead V1 | | |
100160-1 | Knee replacement | | |
100161-9 | Charnley Functional Classification | | |
100162-7 | Knee alignment W standing X-ray measured | | |
100163-5 | Knee medial AndOr lateral instability W full extension | | |
100164-3 | Knee AP instability W 90 degree flexion | | |
100165-0 | Knee range of motion | | |
100166-8 | Flexion contracture range of Knee | | |
100167-6 | Extensor lag range of Knee | | |
100168-4 | Knee pain severity with level walking | | |
100169-2 | Knee pain severity with stairs or inclines | | |
10017-2 | R' wave amplitude in lead V2 | | |
100170-0 | Knee feels normal | | |
100171-8 | Satisfaction with level of knee pain while sitting | | |
100172-6 | Satisfaction with level of knee pain while lying in bed | | |
100173-4 | Satisfaction with knee function while getting out of bed | | |
100174-2 | Satisfaction with knee function while performing light household duties | | |
100175-9 | Satisfaction with knee function while performing recreational activities | | |
100176-7 | Expect surgery to relieve pain | | |
100177-5 | Expect surgery will improve ability to perform activities of daily living | | |
100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities | | |
100179-1 | Walk without assistive mobility devices | | |
10018-0 | R' wave amplitude in lead V3 | | |
100180-9 | Assistive mobility devices used | | |
100181-7 | Assistive mobility devices used due to health condition | | |
100182-5 | Duration of standing before sitting due to knee discomfort | | |
100183-3 | Duration of walking before stopping due to knee discomfort | | |
100184-1 | How bothersome is knee when walking on an uneven surface | | |
100185-8 | How bothersome is knee when turning or pivoting leg | | |
100186-6 | How bothersome is knee when climbing up or down a flight of stairs | | |
100187-4 | How bothersome is knee when getting up from a low seat without armrests | | |
100188-2 | How bothersome is knee when getting into or out of a car | | |
100189-0 | How bothersome is knee when moving laterally | | |
10019-8 | R' wave amplitude in lead V4 | | |
100190-8 | How bothersome is knee when climbing a ladder or step stool | | |
100191-6 | How bothersome is knee when carrying a bag for one block | | |
100192-4 | How bothersome is knee when squatting | | |
100193-2 | How bothersome is knee when kneeling | | |
100194-0 | How bothersome is knee when running | | |
100195-7 | Pain severity--during activity | | |
100196-5 | Pre-op total score [Knee Society Score] | | |
100197-3 | Exercise activity and pain severity panel | | |
100198-1 | Pre-op objective knee indicators score [Knee Society Score] | | |
100199-9 | Pre-op symptoms score [Knee Society Score] | | |
1002-5 | DBG Ab [Presence] in Serum or Plasma | |
10020-6 | R' wave amplitude in lead V5 | | |
100200-5 | Pre-op patient expectations score [Knee Society Score] | | |
100201-3 | Pre-op functional activities score [Knee Society Score] | | |
100202-1 | Pre-op discretionary knee activities score [Knee Society Score] | | |
100203-9 | Knee Society Score post-op panel [Knee Society Score] | | |
100204-7 | Accuracy of pre-surgery expectations of pain relief | | |
100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living | | |
100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | | |
100207-0 | Post-op total score [Knee Society Score] | | |
100208-8 | Post-op objective knee indicators score [Knee Society Score] | | |
100209-6 | Post-op symptoms score [Knee Society Score] | | |
10021-4 | R' wave amplitude in lead V6 | | |
100210-4 | Post-op patient expectations score [Knee Society Score] | | |
100211-2 | Post-op functional activities score [Knee Society Score] | | |
100212-0 | Post-op discretionary knee activities score [Knee Society Score] | | |
100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method | |
100214-6 | Dental model prior authorization Document | | |
100215-3 | Episode of care medical records Document Transplant surgery | | |
100216-1 | Surgical synoptic report | | |
100217-9 | Surgical oncology synoptic report | | |
100218-7 | Surgical oncology of colon synoptic report | | |
100219-5 | Surgical oncology of melanoma synoptic report | | |
10022-2 | R' wave duration in lead AVF | | |
100220-3 | Surgical oncology of breast synoptic report | | |
100221-1 | Surgical oncology of thyroid synoptic report | | |
100222-9 | Surgical oncology of pancreas synoptic report | | |
100223-7 | Physical findings of Retina Narrative | | |
100224-5 | Cardiac left ventricular segmental wall motion by echo panel | | |
100225-2 | Bone density quantitative ultrasound study | | |
100226-0 | Small bowel capsule endoscopy study Document | | |
100227-8 | Colon capsule endoscopy study Document | | |
100228-6 | Upper gastrointestinal capsule endoscopy study Document | | |
100229-4 | Endoscopic ultrasound study Document | | |
10023-0 | R' wave duration in lead AVL | | |
100230-2 | Routine prenatal assessment panel | | |
100231-0 | Endobronchial ultrasound study | | |
100232-8 | Impacts of Events Scale-Revised panel | | |
100233-6 | Reminders brought back feelings about adverse event | | |
100234-4 | Trouble staying asleep | | |
100235-1 | Other things triggered persistent thoughts about adverse event | | |
100236-9 | Felt irritable AndOr angry | | |
100237-7 | Avoided getting upset when unintentionally thought about adverse event | | |
100238-5 | Thought about adverse event unintentionally | | |
100239-3 | Felt as if adverse event did not happen | | |
10024-8 | R' wave duration in lead AVR | | |
100240-1 | Avoided reminders of adverse event | | |
100241-9 | Experienced mental images of adverse event | | |
100242-7 | Easily startled | | |
100243-5 | Tried to not think of adverse event | | |
100244-3 | Aware of feelings about adverse event, but did not address them | | |
100245-0 | Feelings about adverse event were numb | | |
100246-8 | Acted or felt the same as during adverse event | | |
100247-6 | Trouble falling asleep | | |
100248-4 | Waves of strong feelings about adverse event | | |
100249-2 | Tried to remove adverse event from memory | | |
10025-5 | R' wave duration in lead I | | |
100250-0 | Trouble concentrating | | |
100251-8 | Reminders of adverse event caused physical reactions | | |
100252-6 | Had dreams about adverse event | | |
100253-4 | Felt watchful and on-guard | | |
100254-2 | Tried not to talk about adverse event | | |
100255-9 | Total score [Impact of Event Scale-Revised] | | |
100256-7 | Fallen in last 6 months | | |
100257-5 | Feel unsteady when standing or walking | | |
100258-3 | History of fall related injury | | |
100259-1 | Aware of tactile sensations | | |
10026-3 | R' wave duration in lead II | | |
100260-9 | Easy to describe thoughts AndOr feelings | | |
100261-7 | Critical of own thoughts AndOr feelings | | |
100262-5 | Able to notice distressing thoughts AndOr feelings without having to react | | |
100263-3 | Easily distracted | | |
100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed | | |
100265-8 | Aware of dietary intake impact on self | | |
100266-6 | Difficult to describe thoughts AndOr feelings | | |
100267-4 | Aware of auditory stimuli | | |
100268-2 | Able to avoid immediate reaction in difficult situations | | |
100269-0 | Do things without paying attention | | |
10027-1 | R' wave duration in lead III | | |
100270-8 | Recover quickly from distressing thoughts AndOr images | | |
100271-6 | Aware of olfactory stimuli | | |
100272-4 | Aware of visual stimuli | | |
100273-2 | Aware of emotions affect on thoughts AndOr behavior | | |
100274-0 | Observing score [FFMQ] | | |
100275-7 | Describing score [FFMQ] | | |
100276-5 | Acting with awareness score [FFMQ] | | |
100277-3 | Nonjudging score [FFMQ] | | |
100278-1 | Nonreactivity score [FFMQ] | | |
100279-9 | Total score [FFMQ] | | |
10028-9 | R' wave duration in lead V1 | | |
100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] | | |
100281-5 | D Ab [Units/volume] in Serum or Plasma | |
100282-3 | Vaccine exemption certificate | | |
100283-1 | Harris Hip Score panel [Harris Hip Score] | | |
100284-9 | Walking - functional ability | | |
100285-6 | Comfortable seated position | | |
100286-4 | Able to board public transportation | | |
100287-2 | Put on shoes and socks | | |
100288-0 | Absence of deformity score [Harris Hip Score] | | |
100289-8 | Absence of hip deformity measurements | | |
10029-7 | R' wave duration in lead V2 | | |
100290-6 | Range of motion score [Harris Hip Score] | | |
100291-4 | Total score [Harris Hip Score] | | |
100292-2 | Pre-op patient satisfaction score [Knee Society Score] | | |
100293-0 | Hip Flexion range of motion | | |
100294-8 | Hip Abduction range of motion | | |
100295-5 | Hip Adduction range of motion | | |
100296-3 | Hip External rotation range of motion | | |
100297-1 | Hip Internal rotation range of motion | | |
100298-9 | Repetition count | | |
100299-7 | Post-op patient satisfaction score [Knee Society Score] | | |
1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | |
10030-5 | R' wave duration in lead V3 | | |
100300-3 | End time Unspecified body region | | |
100301-1 | Start time Unspecified body region | | |
100302-9 | Time period start and end panel Unspecified body region | | |
100303-7 | Condition certainty of presence | | |
100304-5 | Flights climbed [#] Reporting Period | | |
100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | |
100306-0 | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | |
100307-8 | Behavioral screening elder mistreatment | | |
100308-6 | Need help getting to essential places | | |
100309-4 | Activity support person | | |
10031-3 | R' wave duration in lead V4 | | |
100310-2 | Reliability of support person | | |
100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house | | |
100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house | | |
100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day | | |
100314-4 | Need help with house cleaning or yard work | | |
100315-1 | Need help getting out of bed, showered, or dressed | | |
100316-9 | Need help to make sure bills get paid | | |
100317-7 | Relationship of usual support person for daily activities | | |
100318-5 | Have help with finances AndOr financial decisions | | |
100319-3 | Relationship of financial support person | | |
10032-1 | R' wave duration in lead V5 | | |
100320-1 | Financial support person usually asks for permission before making decisions | | |
100321-9 | Financial support person usually makes good decisions about finances | | |
100322-7 | Have access to paperwork for financial decisions made | | |
100323-5 | Financial support person forged signature | | |
100324-3 | Coercion of financial support person for signing a document in order to get money or possessions | | |
100325-0 | Experienced theft by support person | | |
100326-8 | Money spent or property sold without permission | | |
100327-6 | Stranger forged signature for financial gain | | |
100328-4 | Stranger forced document signature for financial gain | | |
100329-2 | Feared for safety due to verbal attack | | |
10033-9 | R' wave duration in lead V6 | | |
100330-0 | Felt humiliated due to ridicule | | |
100331-8 | Coerced to do something | | |
100332-6 | Ignored by close friend or relative for extended period | | |
100333-4 | Physically hit or threatened | | |
100334-2 | Been physically hurt with some degree of injury | | |
100335-9 | Coerced sexual activity | | |
100336-7 | Coerced touching of private body parts of self or others | | |
100337-5 | Coerced to undress or expose private body area | | |
100338-3 | Photographed in any degree of nudity without consent | | |
100339-1 | Experienced attempted physical restraint | | |
10034-7 | S wave amplitude in lead AVF | | |
100340-9 | Range of motion panel Hip | | |
100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF | |
100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | |
100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | |
100346-6 | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG | |
100347-4 | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG | |
100348-2 | Model for end-stage liver disease sodium score | | |
100349-0 | US.doppler Penis vessels W vasodilator IV | | |
10035-4 | S wave amplitude in lead AVL | | |
100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum | |
100351-6 | Pioglitazone [Presence] in Serum or Plasma | |
100352-4 | Rosiglitazone [Presence] in Serum or Plasma | |
100353-2 | Norwalk Community Health Center Screening Tool [NCHC] | | |
100354-0 | Frequency of participating in multi-modal communication without assistance | | |
100355-7 | Frequency of participating in spoken language expression communication without assistance | | |
100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | |
100357-3 | Naloxone [Presence] in Cord tissue by Screen method | |
100358-1 | Phentermine [Presence] in Cord tissue by Screen method | |
100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay | |
10036-2 | S wave amplitude in lead AVR | | |
100360-7 | Brief Resilience Scale panel [BRS] | | |
100361-5 | Quickly recover from bad events | | |
100362-3 | Difficulty making it through stressful events | | |
100363-1 | Easily recover from a stressful event | | |
100364-9 | Difficulty recovering from bad events | | |
100365-6 | Easily recover from difficulties | | |
100366-4 | Lengthy recovery from setbacks | | |
100367-2 | Total Score BRS | | |
100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS | |
100369-8 | NM Thyroid gland Views W Tl-201 IV | | |
10037-0 | S wave amplitude in lead I | | |
100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | |
100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay | |
100372-2 | Abiraterone [Mass/volume] in Serum or Plasma | |
100373-0 | Eucheuma IgG Ab [Units/volume] in Serum | |
100374-8 | Aloe vera IgG Ab [Units/volume] in Serum | |
100375-5 | Anise IgG Ab [Units/volume] in Serum | |
100376-3 | Bambusa vulgaris IgG Ab [Units/volume] in Serum | |
100377-1 | Goat cheese IgG Ab [Units/volume] in Serum | |
100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum | |
100379-7 | Leeks IgG Ab [Units/volume] in Serum | |
10038-8 | S wave amplitude in lead II | | |
100380-5 | Red cabbage IgG Ab [Units/volume] in Serum | |
100381-3 | Mentha balsamea Wild IgG Ab [Units/volume] in Serum | |
100382-1 | FDA package insert REMS addressed risk | | |
100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | |
100384-7 | Rapeseed IgG Ab [Units/volume] in Serum | |
100385-4 | Corn salad IgG Ab [Units/volume] in Serum | |
100386-2 | Rosemary IgG Ab [Units/volume] in Serum | |
100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum | |
100388-8 | Cocoa IgG Ab [Units/volume] in Serum | |
100389-6 | Pistachio IgG Ab [Units/volume] in Serum | |
10039-6 | S wave amplitude in lead III | | |
100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum | |
100391-2 | Dates IgG Ab [Units/volume] in Serum | |
100392-0 | Duck meat IgG Ab [Units/volume] in Serum | |
100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | |
100394-6 | Astacoidea IgG Ab [Units/volume] in Serum | |
100395-3 | Carob IgG Ab [Units/volume] in Serum | |
100396-1 | Brassica napus IgG Ab [Units/volume] in Serum | |
100397-9 | Goat Meat IgG Ab [Units/volume] in Serum | |
100398-7 | Goose meat IgG Ab [Units/volume] in Serum | |
100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum | |
1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | |
10040-4 | S wave amplitude in lead V1 | | |
100400-1 | Quail meat IgG Ab [Units/volume] in Serum | |
100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum | |
100402-7 | Venison meat IgG Ab [Units/volume] in Serum | |
100403-5 | Guineafowl IgG Ab [Units/volume] in Serum | |
100404-3 | Horse meat IgG Ab [Units/volume] in Serum | |
100405-0 | Kefir IgG Ab [Units/volume] in Serum | |
100406-8 | Butter IgG Ab [Units/volume] in Serum | |
100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum | |
100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum | |
100409-2 | Processed cheese IgG Ab [Units/volume] in Serum | |
10041-2 | S wave amplitude in lead V2 | | |
100410-0 | Curd cheese IgG Ab [Units/volume] in Serum | |
100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum | |
100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum | |
100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum | |
100414-2 | Gourd IgG Ab [Units/volume] in Serum | |
100415-9 | Kale IgG Ab [Units/volume] in Serum | |
100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum | |
100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum | |
100418-3 | Liquorice IgG Ab [Units/volume] in Serum | |
100419-1 | Snow pea IgG Ab [Units/volume] in Serum | |
10042-0 | S wave amplitude in lead V3 | | |
100420-9 | Fava bean IgG Ab [Units/volume] in Serum | |
100421-7 | Chick Pea IgG Ab [Units/volume] in Serum | |
100422-5 | Chicory IgG Ab [Units/volume] in Serum | |
100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum | |
100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma | |
100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma | |
100426-6 | Squalene [Mass/volume] in Serum or Plasma | |
100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma | |
100428-2 | Carnitine free and total and acylcarnitine panel - Urine | |
100429-0 | LRBA deficiency panel - Blood | |
10043-8 | S wave amplitude in lead V4 | | |
100430-8 | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) | |
100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | |
100432-4 | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | |
100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | |
100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | |
100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay | |
100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | |
100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method | |
100438-1 | Adolescent medicine Outpatient Progress note | | |
100439-9 | Allergy and Immunology Outpatient Progress note | | |
10044-6 | S wave amplitude in lead V5 | | |
100440-7 | Allergy Outpatient Progress note | | |
100441-5 | Attending Outpatient Progress note | | |
100442-3 | Audiology Outpatient Progress note | | |
100443-1 | Bariatric surgery Outpatient Progress note | | |
100444-9 | Blood banking and transfusion medicine Outpatient Progress note | | |
100445-6 | Bone Marrow Transplant Outpatient Progress note | | |
100446-4 | Breastfeeding Outpatient Progress note | | |
100447-2 | Burn management Outpatient Progress note | | |
100448-0 | Cardiac surgery Outpatient Progress note | | |
100449-8 | Cardiopulmonary Outpatient Progress note | | |
10045-3 | S wave amplitude in lead V6 | | |
100450-6 | Child and adolescent psychiatry Outpatient Progress note | | |
100451-4 | Chiropractic medicine Outpatient Progress note | | |
100452-2 | Clinical cardiac electrophysiology Outpatient Progress note | | |
100453-0 | Clinical genetics Outpatient Progress note | | |
100454-8 | Clinical neurophysiology Outpatient Progress note | | |
100455-5 | Clinical pathology Outpatient Progress note | | |
100456-3 | Colon and rectal surgery Outpatient Progress note | | |
100457-1 | Consultant Outpatient Progress note | | |
100458-9 | Outpatient COVID-19 Intubation Progress note | | |
100459-7 | Outpatient COVID-19 Progress note | | |
10046-1 | S wave duration in lead AVF | | |
100460-5 | Dermatology Outpatient Progress note | | |
100461-3 | Developmental-behavioral pediatrics Outpatient Progress note | | |
100462-1 | Dialysis and Therapeutic apheresis Outpatient Progress note | | |
100463-9 | Eating disorders Outpatient Progress note | | |
100464-7 | Endocrinology Outpatient Progress note | | |
100465-4 | Family medicine Outpatient Progress note | | |
100466-2 | Gastroenterology Outpatient Progress note | | |
100467-0 | Geriatric medicine Outpatient Progress note | | |
100468-8 | Gynecologic oncology Outpatient Progress note | | |
100469-6 | Gynecology Outpatient Progress note | | |
10047-9 | S wave duration in lead AVL | | |
100470-4 | Healthcare navigator Outpatient Progress note | | |
100471-2 | Heart failure Outpatient Progress note | | |
100472-0 | Heart failure+Transplant cardiology Outpatient Progress note | | |
100473-8 | Hematology Outpatient Progress note | | |
100474-6 | Hematology+Medical oncology Outpatient Progress note | | |
100475-3 | Hepatology Outpatient Progress note | | |
100476-1 | Immunology Outpatient Progress note | | |
100477-9 | Infectious disease Outpatient Progress note | | |
100478-7 | Internal medicine Outpatient Progress note | | |
100479-5 | Interventional cardiology Outpatient Progress note | | |
10048-7 | S wave duration in lead AVR | | |
100480-3 | Interventional radiology Outpatient Progress note | | |
100481-1 | Outpatient Mechanical circulatory support Progress note | | |
100482-9 | Medical Aid in Dying Outpatient Progress note | | |
100483-7 | Mental health Outpatient Progress note | | |
100484-5 | Multi-specialty program Outpatient Progress note | | |
100485-2 | Neonatal perinatal medicine Outpatient Progress note | | |
100486-0 | Nephrology Outpatient Progress note | | |
100487-8 | Neurological surgery Outpatient Progress note | | |
100488-6 | Neurology Outpatient Progress note | | |
100489-4 | Neurology with special qualifications in child neurology Outpatient Progress note | | |
10049-5 | S wave duration in lead I | | |
100490-2 | Nurse practitioner Outpatient Progress note | | |
100491-0 | Nurse Outpatient Progress note | | |
100492-8 | Nutrition and dietetics Outpatient Progress note | | |
100493-6 | Obstetrics and Gynecology Outpatient Progress note | | |
100494-4 | Obstetrics Outpatient Progress note | | |
100495-1 | Occupational therapy Outpatient Progress note | | |
100496-9 | Oncology Outpatient Progress note | | |
100497-7 | Ophthalmology Outpatient Progress note | | |
100498-5 | Optometry Outpatient Progress note | | |
100499-3 | Oral and Maxillofacial Surgery Outpatient Progress note | | |
1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | |
10050-3 | S wave duration in lead II | | |
100500-8 | Orthopaedic surgery Outpatient Progress note | | |
100501-6 | Orthotics prosthetics Outpatient Progress note | | |
100502-4 | Otolaryngology Outpatient Progress note | | |
100503-2 | Pain medicine Outpatient Progress note | | |
100504-0 | Palliative care Outpatient Progress note | | |
100505-7 | Pediatric cardiology Outpatient Progress note | | |
100506-5 | Pediatric dermatology Outpatient Progress note | | |
100507-3 | Pediatric endocrinology Outpatient Progress note | | |
100508-1 | Pediatric gastroenterology Outpatient Progress note | | |
100509-9 | Pediatric hematology-oncology Outpatient Progress note | | |
10051-1 | S wave duration in lead III | | |
100510-7 | Pediatric infectious diseases Outpatient Progress note | | |
100511-5 | Pediatric otolaryngology Outpatient Progress note | | |
100512-3 | Pediatric pulmonology Outpatient Progress note | | |
100513-1 | Pediatric rheumatology Outpatient Progress note | | |
100514-9 | Pediatric surgery Outpatient Progress note | | |
100515-6 | Pediatric transplant hepatology Outpatient Progress note | | |
100516-4 | Pediatric urology Outpatient Progress note | | |
100517-2 | Pharmacogenomics Outpatient Progress note | | |
100518-0 | Physical medicine and rehab Outpatient Progress note | | |
100519-8 | Physical therapy Outpatient Progress note | | |
10052-9 | S wave duration in lead V1 | | |
100520-6 | Plastic surgery Outpatient Progress note | | |
100521-4 | Podiatry Outpatient Progress note | | |
100522-2 | Psychiatry Hospital Progress note | | |
100523-0 | Psychology Outpatient Progress note | | |
100524-8 | Pulmonary Outpatient Progress note | | |
100525-5 | Radiation oncology Outpatient Progress note | | |
100526-3 | Radiology Outpatient Progress note | | |
100527-1 | Recreational therapy Outpatient Progress note | | |
100528-9 | Reproductive endocrinology and infertility Outpatient Progress note | | |
100529-7 | Research Outpatient Progress note | | |
10053-7 | S wave duration in lead V2 | | |
100530-5 | Rheumatology Outpatient Progress note | | |
100531-3 | Sleep medicine Outpatient Progress note | | |
100532-1 | Social worker Outpatient Progress note | | |
100533-9 | Solid Organ Transplant Outpatient Progress note | | |
100534-7 | Speech-language pathology Outpatient Progress note | | |
100535-4 | Spinal surgery Outpatient Progress note | | |
100536-2 | Sports medicine Outpatient Progress note | | |
100537-0 | Surgery of the hand Outpatient Progress note | | |
100538-8 | Telehealth+Outpatient Progress note | | |
100539-6 | Thromboembolism Outpatient Progress note | | |
10054-5 | S wave duration in lead V3 | | |
100540-4 | Transplant surgery Outpatient Progress note | | |
100541-2 | Trauma Outpatient Progress note | | |
100542-0 | Urology Outpatient Progress note | | |
100543-8 | Vascular neurology Outpatient Progress note | | |
100544-6 | Vascular surgery Outpatient Progress note | | |
100545-3 | Wound care management Outpatient Progress note | | |
100546-1 | Wound, Ostomy, and Continence Care Outpatient Progress note | | |
100547-9 | Adolescent medicine Hospital Progress note | | |
100548-7 | Allergy and Immunology Hospital Progress note | | |
100549-5 | Allergy Hospital Progress note | | |
10055-2 | S wave duration in lead V4 | | |
100550-3 | Attending Hospital Progress note | | |
100551-1 | Audiology Hospital Progress note | | |
100552-9 | Bariatric surgery Hospital Progress note | | |
100553-7 | Blood banking and transfusion medicine Hospital Progress note | | |
100554-5 | Bone Marrow Transplant Hospital Progress note | | |
100555-2 | Breastfeeding Hospital Progress note | | |
100556-0 | Burn management Hospital Progress note | | |
100557-8 | Cardiac surgery Hospital Progress note | | |
100558-6 | Cardiopulmonary Hospital Progress note | | |
100559-4 | Child and adolescent psychiatry Hospital Progress note | | |
10056-0 | S wave duration in lead V5 | | |
100560-2 | Clinical cardiac electrophysiology Hospital Progress note | | |
100561-0 | Clinical genetics Hospital Progress note | | |
100562-8 | Clinical neurophysiology Hospital Progress note | | |
100563-6 | Clinical pathology Hospital Progress note | | |
100564-4 | Colon and rectal surgery Hospital Progress note | | |
100565-1 | Consultant Hospital Progress note | | |
100566-9 | Dentistry Hospital Progress note | | |
100567-7 | Dermatology Hospital Progress note | | |
100568-5 | Developmental-behavioral pediatrics Hospital Progress note | | |
100569-3 | Dialysis and Therapeutic apheresis Hospital Progress note | | |
10057-8 | S wave duration in lead V6 | | |
100570-1 | Eating disorders Hospital Progress note | | |
100571-9 | Endocrinology Hospital Progress note | | |
100572-7 | Family medicine Hospital Progress note | | |
100573-5 | Gastroenterology Hospital Progress note | | |
100574-3 | General medicine Hospital Progress note | | |
100575-0 | Geriatric medicine Hospital Progress note | | |
100576-8 | Gynecologic oncology Hospital Progress note | | |
100577-6 | Gynecology Hospital Progress note | | |
100578-4 | Healthcare navigator Hospital Progress note | | |
100579-2 | Heart failure Hospital Progress note | | |
10058-6 | S' wave amplitude in lead AVF | | |
100580-0 | Heart failure+Transplant cardiology Hospital Progress note | | |
100581-8 | Hematology Hospital Progress note | | |
100582-6 | Hematology+Medical oncology Hospital Progress note | | |
100583-4 | Hepatology Hospital Progress note | | |
100584-2 | Immunology Hospital Progress note | | |
100585-9 | Infectious disease Hospital Progress note | | |
100586-7 | Internal medicine Hospital Progress note | | |
100587-5 | Interventional cardiology Hospital Progress note | | |
100588-3 | Interventional radiology Hospital Progress note | | |
100589-1 | Hospital Mechanical circulatory support Progress note | | |
10059-4 | S' wave amplitude in lead AVL | | |
100590-9 | Medical Aid in Dying Hospital Progress note | | |
100591-7 | Mental health Hospital Progress note | | |
100592-5 | Multi-specialty program Hospital Progress note | | |
100593-3 | Neonatal perinatal medicine Hospital Progress note | | |
100594-1 | Nephrology Hospital Progress note | | |
100595-8 | Neurological surgery Hospital Progress note | | |
100596-6 | Neurology Hospital Progress note | | |
100597-4 | Neurology with special qualifications in child neurology Hospital Progress note | | |
100598-2 | Nurse practitioner Hospital Progress note | | |
100599-0 | Nurse Hospital Progress note | | |
1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | |
10060-2 | S' wave amplitude in lead AVR | | |
100600-6 | Nutrition and dietetics Hospital Progress note | | |
100601-4 | Obstetrics and Gynecology Hospital Progress note | | |
100602-2 | Obstetrics Hospital Progress note | | |
100603-0 | Occupational therapy Hospital Progress note | | |
100604-8 | Oncology Hospital Progress note | | |
100605-5 | Ophthalmology Hospital Progress note | | |
100606-3 | Oral and Maxillofacial Surgery Hospital Progress note | | |
100607-1 | Orthopaedic surgery Hospital Progress note | | |
100608-9 | Orthotics prosthetics Hospital Progress note | | |
100609-7 | Otolaryngology Hospital Progress note | | |
10061-0 | S' wave amplitude in lead I | | |
100610-5 | Pain medicine Hospital Progress note | | |
100611-3 | Palliative care Hospital Progress note | | |
100612-1 | Pastoral care Hospital Progress note | | |
100613-9 | Pediatric cardiology Hospital Progress note | | |
100614-7 | Pediatric dermatology Hospital Progress note | | |
100615-4 | Pediatric endocrinology Hospital Progress note | | |
100616-2 | Pediatric gastroenterology Hospital Progress note | | |
100617-0 | Pediatric hematology-oncology Hospital Progress note | | |
100618-8 | Pediatric infectious diseases Hospital Progress note | | |
100619-6 | Pediatric otolaryngology Hospital Progress note | | |
10062-8 | S' wave amplitude in lead II | | |
100620-4 | Pediatric pulmonology Hospital Progress note | | |
100621-2 | Pediatric rheumatology Hospital Progress note | | |
100622-0 | Pediatric surgery Hospital Progress note | | |
100623-8 | Pediatric transplant hepatology Hospital Progress note | | |
100624-6 | Pharmacogenomics Hospital Progress note | | |
100625-3 | Pharmacology Hospital Progress note | | |
100626-1 | Physical medicine and rehab Hospital Progress note | | |
100627-9 | Physical therapy Hospital Progress note | | |
100628-7 | Plastic surgery Hospital Progress note | | |
100629-5 | Podiatry Hospital Progress note | | |
10063-6 | S' wave amplitude in lead III | | |
100630-3 | Psychology Hospital Progress note | | |
100631-1 | Radiation oncology Hospital Progress note | | |
100632-9 | Radiology Hospital Progress note | | |
100633-7 | Rapid response team Hospital Progress note | | |
100634-5 | Recreational therapy Hospital Progress note | | |
100635-2 | Reproductive endocrinology and infertility Hospital Progress note | | |
100636-0 | Research Hospital Progress note | | |
100637-8 | Rheumatology Hospital Progress note | | |
100638-6 | Sleep medicine Hospital Progress note | | |
100639-4 | Social worker Hospital Progress note | | |
10064-4 | S' wave amplitude in lead V1 | | |
100640-2 | Solid Organ Transplant Hospital Progress note | | |
100641-0 | Speech-language pathology Hospital Progress note | | |
100642-8 | Spinal surgery Hospital Progress note | | |
100643-6 | Surgery of the hand Hospital Progress note | | |
100644-4 | Thromboembolism Hospital Progress note | | |
100645-1 | Trauma Hospital Progress note | | |
100646-9 | Urology Hospital Progress note | | |
100647-7 | Vascular neurology Hospital Progress note | | |
100648-5 | Vascular surgery Hospital Progress note | | |
100649-3 | Wound care management Hospital Progress note | | |
10065-1 | S' wave amplitude in lead V2 | | |
100650-1 | Wound, Ostomy, and Continence Care Hospital Progress note | | |
100651-9 | Hospital COVID-19 Intubation Progress note | | |
100652-7 | Pure tone bone conduction threshold audiometry panel | | |
100653-5 | Pure tone air conduction threshold audiometry panel | | |
100654-3 | Pyruvate kinase M2 [Presence] in Stool | |
100655-0 | XR Sella turcica Lateral | | |
100656-8 | Maternal and fetal medicine Outpatient Progress note | | |
100657-6 | Maternal and fetal medicine Telephone encounter+Hospital Progress note | | |
100658-4 | Hospital COVID-19 Progress note | | |
100659-2 | Maternal and fetal medicine Hospital Progress note | | |
10066-9 | S' wave amplitude in lead V3 | | |
100660-0 | Maternal and fetal medicine Telephone encounter+Outpatient Progress note | | |
100661-8 | Psychiatry Outpatient Progress note | | |
100662-6 | Cortisol free and total panel - Serum or Plasma | |
100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method | |
100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method | |
100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method | |
100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method | |
100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method | |
100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method | |
100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method | |
10067-7 | S' wave amplitude in lead V4 | | |
100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus | |
100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection | |
100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection | |
100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection | |
100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | |
100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | |
100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
10068-5 | S' wave amplitude in lead V5 | | |
100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | |
100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | |
100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection | |
10069-3 | S' wave amplitude in lead V6 | | |
100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection | |
100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | |
100693-1 | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection | |
100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method | |
100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative | |
100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal | |
100697-2 | Interventional radiology Outpatient Note | | |
100698-0 | Social Determinants of Health screening report Document | | |
100699-8 | Rifabutin+Ethambutol [Susceptibility] | |
1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | |
10070-1 | S' wave duration in lead AVF | | |
100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection | |
100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection | |
100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection | |
100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection | |
100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection | |
100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection | |
100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection | |
100707-9 | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count | |
100708-7 | Plasma cells/100 leukocytes in Synovial fluid | |
100709-5 | Hepatocellular carcinoma risk [Score] by GAAD | |
10071-9 | S' wave duration in lead AVL | | |
100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection | |
100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay | |
100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma | |
100713-7 | Cariprazine [Mass/volume] in Serum or Plasma | |
100714-5 | Guanfacine [Mass/volume] in Serum or Plasma | |
100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma | |
100716-0 | Prostate specific Ag [Mass/volume] in DBS | |
100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method | |
100718-6 | Undersea and hyperbaric medicine Discharge summary | | |
100719-4 | Surgical oncology Discharge summary | | |
10072-7 | S' wave duration in lead AVR | | |
100720-2 | Reproductive endocrinology and infertility Discharge summary | | |
100721-0 | Community health care Discharge summary | | |
100722-8 | Integrative medicine Discharge summary | | |
100723-6 | Sports medicine Discharge summary | | |
100724-4 | Diabetology Discharge summary | | |
100725-1 | Optometry Discharge summary | | |
100726-9 | Podiatry Discharge summary | | |
100727-7 | Chiropractic medicine Discharge summary | | |
100728-5 | Cardiac surgery Discharge summary | | |
100729-3 | Breastfeeding Discharge summary | | |
10073-5 | S' wave duration in lead I | | |
100730-1 | Transplant surgery Discharge summary | | |
100731-9 | Urgent care center Discharge summary | | |
100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum | |
100733-5 | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) | |
100734-3 | traMADol and Metabolites Panel - Urine by Confirmatory method | |
100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes | |
100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document | |
100737-6 | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma | |
100738-4 | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma | |
100739-2 | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma | |
10074-3 | S' wave duration in lead II | | |
100740-0 | Amylase.macromolecular [Presence] in Serum or Plasma | |
100741-8 | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma | |
100742-6 | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma | |
100743-4 | Lipase.macromolecular [Presence] in Serum or Plasma | |
100744-2 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis | |
100745-9 | Chloride [Moles/volume] in Mixed venous blood | |
100746-7 | Glucose [Moles/volume] in Mixed venous blood | |
100747-5 | Legionella serogroup panel - Specimen | |
100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection | |
100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection | |
10075-0 | S' wave duration in lead III | | |
100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection | |
100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma | |
100752-5 | Exacerbating factors - Reported | | |
100753-3 | Alleviating factors - Reported | | |
100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing | |
100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | |
100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing | |
100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing | |
100758-2 | Estimated lung age by based on clinical data | | |
100759-0 | Inspiratory reserve [Volume] Respiratory system by Spirometry | | |
10076-8 | S' wave duration in lead V1 | | |
100760-8 | XR Radius and Ulna - left Single view | | |
100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | |
100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method | |
100763-2 | Mycobacterium sp comparative reaction interpretation Narrative | |
100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal | |
100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS | |
100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] | | |
100767-3 | Bothered by things that are not usually bothersome | | |
100768-1 | Poor appetite | | |
100769-9 | Unhappy even with help from my family or friends | | |
10077-6 | S' wave duration in lead V2 | | |
100770-7 | Feeling just as good as others | | |
100771-5 | Trouble focusing | | |
100772-3 | Feeling depressed | | |
100773-1 | Feeling everything is too much of an effort | | |
100774-9 | Feeling hopeful about the future | | |
100775-6 | Feeling life had been a failure | | |
100776-4 | Feeling fearful | | |
100777-2 | Restless sleep | | |
100778-0 | Feeling happy | | |
100779-8 | Quieter than usual | | |
10078-4 | S' wave duration in lead V3 | | |
100780-6 | Feeling lonely | | |
100781-4 | People were unfriendly | | |
100782-2 | Enjoying life | | |
100783-0 | Crying spells | | |
100784-8 | Feeling sad | | |
100785-5 | Feeling people dislike me | | |
100786-3 | Lack of energy | | |
100787-1 | Total Score CES-D | | |
100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum | |
100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | |
10079-2 | S' wave duration in lead V4 | | |
100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum | |
100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum | |
100792-1 | Forsythia IgE Ab [Units/volume] in Serum | |
100793-9 | Testosterone [Mass/volume] in Body fluid | |
100794-7 | Follitropin [Units/volume] in Body fluid | |
100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid | |
100796-2 | Thyroglobulin [Mass/volume] in Body fluid | |
100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge | |
100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge | |
100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | |
1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | |
10080-0 | S' wave duration in lead V5 | | |
100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge | |
100801-0 | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge | |
100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge | |
100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | |
100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge | |
100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | |
100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge | |
100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | |
100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge | |
100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | |
10081-8 | S' wave duration in lead V6 | | |
100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge | |
100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | |
100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge | |
100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | |
100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge | |
100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | |
100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | |
100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | |
100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge | |
100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | |
10082-6 | ST initial amplitude 6 ms in lead AVF | | |
100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge | |
100821-8 | National POLST form: portable medical order panel | | |
100822-6 | Cardiopulmonary resuscitation orders | | |
100823-4 | Initial portable medical treatment orders | | |
100824-2 | Additional portable medical orders or instructions | | |
100825-9 | Medically assisted nutrition orders | | |
100826-7 | Portable medical order AndOr advance directive review | | |
100827-5 | Portable medical order discussion participants | | |
100828-3 | Portable medical order administrative information | | |
100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge | |
10083-4 | ST initial amplitude 6 ms in lead AVL | | |
100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge | |
100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | |
100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | |
100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | |
100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | |
100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | |
100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | |
100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | |
100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | |
100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma | |
10084-2 | ST initial amplitude 6 ms in lead AVR | | |
100840-8 | IgE [Units/volume] in Body fluid | |
100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot | |
100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST | |
100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ | |
100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 | |
100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) | |
100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | |
100847-3 | Gas and ammonia panel - Arterial blood | |
100848-1 | Cell count and Differential panel - Amniotic fluid by Manual count | |
100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count | |
10085-9 | ST initial amplitude 6 ms in lead I | | |
100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count | |
100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count | |
100852-3 | NM Bones Views for metastasis W Sr-89 IV | | |
100853-1 | NM Pericardial space Pericardial effusion | | |
100854-9 | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay | |
100855-6 | CD3 cells/100 cells in Blood mononuclear cells | |
100856-4 | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells | |
100857-2 | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells | |
100858-0 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
10086-7 | ST initial amplitude 6 ms in lead II | | |
100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
100861-4 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method | |
100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection | |
100866-3 | Febrile antibody profile in Serum | |
100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay | |
100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method | |
100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method | |
10087-5 | ST initial amplitude 6 ms in lead III | | |
100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method | |
100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method | |
100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate | |
100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method | |
100874-7 | Basidiobolus sp [Presence] in Specimen | |
100875-4 | Fetal Heart Document limited US | | |
100876-2 | Fetal Heart Document US | | |
100877-0 | US Heart Transesophageal during surgery | | |
100878-8 | Endoscopic ultrasound study Upper GI tract Document | | |
100879-6 | US Guidance for cryoablation of Breast - right | | |
10088-3 | ST initial amplitude 6 ms in lead V1 | | |
100880-4 | US Guidance for cryoablation of Breast - left | | |
100881-2 | MR Guidance for cryoablation of Bone | | |
100882-0 | MR Peritoneum W contrast percutaneous intraperitoneal | | |
100883-8 | MR Guidance for biopsy of Kidney - left | | |
100884-6 | MR Guidance for biopsy of Kidney - right | | |
100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection | |
100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection | |
100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection | |
100888-7 | West African monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | |
100889-5 | Congo Basin monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | |
10089-1 | ST initial amplitude 6 ms in lead V2 | | |
100890-3 | Poxvirus DNA panel | |
100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | |
100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | |
100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | |
100894-5 | Recommended screening frequency Narrative | | |
100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum | |
100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | |
100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture | |
100898-6 | Lipid panel - Serum or Plasma | |
100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture | |
1009-0 | | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | |
100900-0 | | Enterobacteriaceae.carbapenem resistance panel - Anal by Organism specific culture | |
100901-8 | | Enterobacteriaceae.carbapenemase resistance phenotype [Identifier] in Anal by Organism specific culture | |
100902-6 | | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 [Identifier] in Anal by Organism specific culture | |
100903-4 | | Yeast and Candida sp identification panel - Specimen by Organism specific culture | |
100904-2 | | Urinary tract pathogens panel - Urine by Culture | |
100905-9 | | Gram positive bacteria identified in Isolate by Organism specific culture | |
100906-7 | | Bacteria [#/volume] in Urine by Culture | |
100907-5 | | Vancomycin resistant enterococcus [Identifier] in Specimen by Organism specific culture | |
100908-3 | | Pseudomonas aeruginosa [Presence] in Lower respiratory specimen by Organism specific culture | |
100909-1 | | Cronobacter sakazakii [Presence] by Organism specific culture | |
100910-9 | | Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture | |
100911-7 | | Campylobacter sp [Presence] in Stool by Organism specific culture | |
100912-5 | | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel | |
100913-3 | | Staph aureus and MRSA screening panel - Specimen by Organism specific culture | |
100914-1 | | Protein.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis | |
100915-8 | | Burr cells [Presence] in Body fluid by Light microscopy | |
100962-0 | | Dengue virus Ab.IgG Panel - Serum, Plasma or Blood | |
100963-8 | | Dengue virus 1+2+3+4 nsP1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | |
100964-6 | | Dengue virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | |
100965-3 | | Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood | |
100968-7 | | Bovine tuberculosis comparative cervical test panel - Skin | |
101-6 | | Cefoperazone [Susceptibility] by Disk diffusion (KB) | |
1010-8 | | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit | |
1011-6 | | E sup(w) Ab [Presence] in Serum or Plasma from Donor | |
1012-4 | | E sup(w) Ab [Presence] in Serum or Plasma | |
1013-2 | | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit | |
1014-0 | | E sup(w) Ag [Presence] on Red Blood Cells from Donor | |
1015-7 | | E sup(w) Ag [Presence] on Red Blood Cells | |
1016-5 | | E Ab [Presence] in Serum or Plasma from Blood product unit | |
1017-3 | | E Ab [Presence] in Serum or Plasma from Donor | |
1018-1 | | E Ab [Presence] in Serum or Plasma | |
1019-9 | | E Ag [Presence] on Red Blood Cells from Blood product unit | |
102-4 | | Cefoperazone [Susceptibility] by Serum bactericidal titer | |
1020-7 | | E Ag [Presence] on Red Blood Cells from Donor | |
1021-5 | | E Ag [Presence] on Red Blood Cells | |
1022-3 | | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | |
10226-9 | | Oxygen content in Intravascular space | |
1023-1 | | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor | |
10232-7 | | Oxygen content in Aorta root | |
10233-5 | | Oxygen content in Left atrium | |
10234-3 | | Oxygen content in Right atrium | |
10235-0 | | Oxygen content in High right atrium | |
10236-8 | | Oxygen content in Low right atrium | |
10237-6 | | Oxygen content in Mid right atrium | |
10238-4 | | Oxygen content in Left ventricle | |
10239-2 | | Oxygen content in Right ventricular outflow tract | |
1024-9 | | Fy sup(a) Ab [Presence] in Serum or Plasma | |
10240-0 | | Oxygen content in Right ventricle | |
10241-8 | | Oxygen content in Coronary sinus | |
10242-6 | | Oxygen content in Ductus arteriosus | |
10243-4 | | Oxygen content in Inferior vena cava | |
10244-2 | | Oxygen content in Left pulmonary artery | |
10245-9 | | Oxygen content in Main pulmonary artery | |
10246-7 | | Oxygen content in Right pulmonary artery | |
10247-5 | | Oxygen content in Pulmonary wedge | |
10248-3 | | Oxygen content in Superior vena cava | |
1025-6 | | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | |
1026-4 | | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor | |
1027-2 | | Fy sup(a) Ag [Presence] on Red Blood Cells | |
1028-0 | | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | |
1029-8 | | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor | |
103-2 | | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) | |
1030-6 | | Fy sup(b) Ab [Presence] in Serum or Plasma | |
1031-4 | | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | |
1032-2 | | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor | |
10327-5 | | Eosinophils/100 leukocytes in Sputum by Manual count | |
10328-3 | | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count | |
10329-1 | | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count | |
1033-0 | | Fy sup(b) Ag [Presence] on Red Blood Cells | |
10330-9 | | Monocytes/100 leukocytes in Body fluid by Manual count | |
10331-7 | | Rh [Type] in Blood | |
10332-5 | | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM | |
10333-3 | | Appearance of Cerebral spinal fluid | |
10334-1 | | Cancer Ag 125 [Units/volume] in Serum or Plasma | |
10335-8 | | Color of Cerebral spinal fluid | |
10336-6 | | Gonadotropin peptide [Mass/volume] in Urine | |
10337-4 | | Procollagen type I [Mass/volume] in Serum | |
10338-2 | | Barbiturates [Mass/volume] in Serum or Plasma | |
10339-0 | | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | |
1034-8 | | Fetal cell screen [Interpretation] in Blood | |
10340-8 | | Molindone [Mass/volume] in Serum or Plasma | |
10341-6 | | Norpropoxyphene [Mass/volume] in Serum or Plasma | |
10342-4 | | Sulfamethoxazole [Mass/volume] in Serum or Plasma | |
10343-2 | | Temazepam [Mass/volume] in Serum or Plasma | |
10344-0 | | Tranylcypromine [Mass/volume] in Serum or Plasma | |
10345-7 | | Trihexyphenidyl [Mass/volume] in Urine | |
10346-5 | | Hemoglobin A [Units/volume] in Blood by Electrophoresis | |
10347-3 | | Babesia microti identified in Blood by Light microscopy | |
10348-1 | | Bordetella parapertussis Ab [Presence] in Serum | |
10349-9 | | Brucella sp Ab [Units/volume] in Serum | |
1035-5 | | Fresh frozen plasma given [Volume] | |
10350-7 | | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay | |
10351-5 | | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | |
10352-3 | | Bacteria identified in Genital specimen by Aerobe culture | |
10353-1 | | Bacteria identified in Nose by Aerobe culture | |
10354-9 | | Bacteria identified in Urethra by Culture | |
10355-6 | | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain | |
10356-4 | | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain | |
10357-2 | | Microscopic observation [Identifier] in Wound by Gram stain | |
10358-0 | | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) | |
10359-8 | | Asialoganglioside GM1 IgM Ab [Titer] in Serum | |
1036-3 | | G Ab [Presence] in Serum or Plasma from Blood product unit | |
10360-6 | | DNA single strand IgG Ab [Units/volume] in Serum | |
10361-4 | | DNA single strand IgM Ab [Units/volume] in Serum | |
10362-2 | | Endomysium IgA Ab [Presence] in Serum | |
10363-0 | | Barbiturates [Presence] in Specimen | |
10364-8 | | Cotinine [Mass/mass] in Hair | |
10365-5 | | Cotinine [Mass/volume] in Serum or Plasma | |
10366-3 | | Cotinine [Mass/volume] in Urine | |
10367-1 | | Ethanol [Mass/volume] in Gastric fluid | |
10368-9 | | Lead [Mass/volume] in Capillary blood | |
10369-7 | | Opiates [Mass/mass] in Hair | |
1037-1 | | G Ab [Presence] in Serum or Plasma from Donor | |
10370-5 | | Phencyclidine [Mass/mass] in Hair | |
10371-3 | | Bite cells [Presence] in Blood by Light microscopy | |
10372-1 | | Blister cells [Presence] in Blood by Light microscopy | |
10373-9 | | Fragments [Presence] in Blood by Light microscopy | |
10374-7 | | Helmet cells [Presence] in Blood by Light microscopy | |
10375-4 | | Irregularly contracted cells [Presence] in Blood by Light microscopy | |
10376-2 | | Oval macrocytes [Presence] in Blood by Light microscopy | |
10377-0 | | Pencil cells [Presence] in Blood by Light microscopy | |
10378-8 | | Polychromasia [Presence] in Blood by Light microscopy | |
10379-6 | | Erythrocytes.dual population [Presence] in Blood by Light microscopy | |
1038-9 | | G Ab [Presence] in Serum or Plasma | |
10380-4 | | Stomatocytes [Presence] in Blood by Light microscopy | |
10381-2 | | Target cells [Presence] in Blood by Light microscopy | |
10382-0 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
10383-8 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Donor | |
10384-6 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells | |
10385-3 | | Albumin concentration given | |
10386-1 | | Albumin given [Volume] | |
10387-9 | | Autologous erythrocytes given [Volume] | |
10388-7 | | Autologous whole blood given [Volume] | |
10389-5 | | Blood product.other [Type] | |
1039-7 | | G Ag [Presence] on Red Blood Cells from Blood product unit | |
10390-3 | | Blood product special preparation [Type] | |
10391-1 | | Cytomegalovirus immune globulin given [Volume] | |
10392-9 | | Cryoprecipitate given [Volume] | |
10393-7 | | Factor IX given [Type] | |
10394-5 | | Factor IX given [Volume] | |
10395-2 | | Factor VIII given [Type] | |
10396-0 | | Factor VIII given [Volume] | |
10397-8 | | Hepatitis B immune globulin given [Volume] | |
10398-6 | | I Ag [Presence] on Red Blood Cells from Blood product unit | |
10399-4 | | I Ag [Presence] on Red Blood Cells from Donor | |
104-0 | | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) | |
1040-5 | | G Ag [Presence] on Red Blood Cells from Donor | |
10400-0 | | I Ag [Presence] on Red Blood Cells | |
10401-8 | | Immune serum globulin given [Type] | |
10402-6 | | Immune serum globulin given [Volume] | |
10403-4 | | Inject immune serum globulin [Volume] | |
10404-2 | | Inject Rh immune globulin [Volume] | |
10405-9 | | Inject varicella zoster virus immune globulin [Volume] | |
10406-7 | | little i Ag [Presence] on Red Blood Cells from Blood product unit | |
10407-5 | | little i Ag [Presence] on Red Blood Cells from Donor | |
10408-3 | | little i Ag [Presence] on Red Blood Cells | |
10409-1 | | Pentaspan given [Volume] | |
1041-3 | | G Ag [Presence] on Red Blood Cells | |
10410-9 | | Plasma given [Type] | |
10411-7 | | Plasma given [Volume] | |
10412-5 | | Platelets given [Type] | |
10413-3 | | Rh immune globulin given [Volume] | |
10414-1 | | Transfuse albumin [Volume] | |
10415-8 | | Transfuse blood exchange transfusion [Volume] | |
10416-6 | | Transfuse blood product other [Volume] | |
10417-4 | | Transfuse cryoprecipitate [Volume] | |
10418-2 | | Transfuse factor IX [Volume] | |
10419-0 | | Transfuse factor VIII [Volume] | |
1042-1 | | H Ab [Presence] in Serum or Plasma from Blood product unit | |
10420-8 | | Transfuse immune serum globulin [Volume] | |
10421-6 | | Transfuse Pentaspan [Volume] | |
10422-4 | | Transfuse plasma [Volume] | |
10423-2 | | Transfuse platelets [Volume] | |
10424-0 | | Transfuse erythrocytes [Volume] | |
10425-7 | | Transfuse Rh immune globulin [Volume] | |
10426-5 | | Transfuse whole blood [Volume] | |
10427-3 | | Transfuse whole blood autologous [Volume] | |
10428-1 | | Varicella zoster virus immune globulin given [Volume] | |
10429-9 | | AE 1 Ag [Presence] in Tissue by Immune stain | |
1043-9 | | H Ab [Presence] in Serum or Plasma from Donor | |
10430-7 | | AE 3 Ag [Presence] in Tissue by Immune stain | |
10431-5 | | B-cell Ag [Presence] in Tissue by Immune stain | |
10432-3 | | CD30 Ag [Presence] in Tissue by Immune stain | |
10433-1 | | BR-2 Ag [Presence] in Tissue by Immune stain | |
10434-9 | | Complement C3 Ag [Presence] in Tissue by Immune stain | |
10435-6 | | C5B-9 Ag [Presence] in Tissue by Immune stain | |
10436-4 | | CD15 Ag [Presence] in Tissue by Immune stain | |
10437-2 | | CD16 Ag [Presence] in Tissue by Immune stain | |
10438-0 | | CD20 Ag [Presence] in Tissue by Immune stain | |
10439-8 | | CD3 Ag [Presence] in Tissue by Immune stain | |
1044-7 | | H Ab [Presence] in Serum | |
10440-6 | | Deprecated CD30 Ag [Presence] in Tissue by Immune stain | |
10441-4 | | CD34 Ag [Presence] in Tissue by Immune stain | |
10442-2 | | CD56 Ag [Presence] in Tissue by Immune stain | |
10443-0 | | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain | |
10444-8 | | CD57 Ag [Presence] in Tissue by Immune stain | |
10445-5 | | CD11c Ag [Presence] in Tissue by Immune stain | |
10446-3 | | Leukocyte common Ag [Presence] in Tissue by Immune stain | |
10447-1 | | M-5 Ag [Presence] in Tissue by Immune stain | |
10448-9 | | T-cell Ag [Presence] in Tissue by Immune stain | |
10449-7 | | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal | |
1045-4 | | Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unit | |
10450-5 | | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting | |
10451-3 | | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting | |
10452-1 | | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO | |
10453-9 | | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO | |
10454-7 | | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO | |
10455-4 | | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO | |
10456-2 | | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting | |
10457-0 | | Actin Ag [Presence] in Tissue by Immune stain | |
10458-8 | | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain | |
10459-6 | | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain | |
1046-2 | | Deprecated H NOS Ab [Presence] in Serum or Plasma from Donor | |
10460-4 | | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain | |
10461-2 | | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain | |
10462-0 | | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain | |
10463-8 | | Amyloid A component Ag [Presence] in Tissue by Immune stain | |
10464-6 | | Amyloid P component Ag [Presence] in Tissue by Immune stain | |
10465-3 | | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain | |
10466-1 | | Anion gap 3 in Serum or Plasma | |
10467-9 | | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain | |
10468-7 | | Calcitonin Ag [Presence] in Tissue by Immune stain | |
10469-5 | | Carcinoembryonic Ag [Presence] in Tissue by Immune stain | |
1047-0 | | Deprecated H NOS Ab [Presence] in Serum or Plasma | |
10470-3 | | Choriogonadotropin Ag [Presence] in Tissue by Immune stain | |
10471-1 | | Chromogranin A Ag [Presence] in Tissue by Immune stain | |
10472-9 | | Chromogranin Ag [Presence] in Tissue by Immune stain | |
10473-7 | | Chymotrypsin Ag [Presence] in Tissue by Immune stain | |
10474-5 | | Collagen type 4 Ag [Presence] in Tissue by Immune stain | |
10475-2 | | Corticotropin Ag [Presence] in Tissue by Immune stain | |
10476-0 | | Desmin Ag [Presence] in Tissue by Immune stain | |
10477-8 | | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain | |
10478-6 | | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain | |
10479-4 | | CD227 Ag [Presence] in Tissue by Immune stain | |
1048-8 | | Deprecated H NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
10480-2 | | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain | |
10481-0 | | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain | |
10482-8 | | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain | |
10483-6 | | Gastrin Ag [Presence] in Tissue by Immune stain | |
10484-4 | | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain | |
10485-1 | | Glucagon Ag [Presence] in Tissue by Immune stain | |
10486-9 | | Hemoglobin Ag [Presence] in Tissue by Immune stain | |
10487-7 | | HMB-45 Ag [Presence] in Tissue by Immune stain | |
10488-5 | | IgA Ag [Presence] in Tissue by Immune stain | |
10489-3 | | IgA.heavy chain Ag [Presence] in Tissue by Immune stain | |
1049-6 | | Deprecated H NOS Ag [Presence] on Red Blood Cells from Donor | |
10490-1 | | IgE Ag [Presence] in Tissue by Immune stain | |
10491-9 | | IgG Ag [Presence] in Tissue by Immune stain | |
10492-7 | | IgG.heavy chain Ag [Presence] in Tissue by Immune stain | |
10493-5 | | IgM Ag [Presence] in Tissue by Immune stain | |
10494-3 | | IgM.heavy chain Ag [Presence] in Tissue by Immune stain | |
10495-0 | | Insulin Ag [Presence] in Tissue by Immune stain | |
10496-8 | | Kappa light chains Ag [Presence] in Tissue by Immune stain | |
10497-6 | | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain | |
10498-4 | | Keratin Ag [Presence] in Tissue by Immune stain | |
10499-2 | | Lambda light chains Ag [Presence] in Tissue by Immune stain | |
105-7 | | Ceforanide [Susceptibility] by Disk diffusion (KB) | |
1050-4 | | Deprecated H NOS Ag [Presence] on Red Blood Cells | |
10500-7 | | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain | |
10501-5 | | Lutropin [Units/volume] in Serum or Plasma | |
10502-3 | | Lutropin Ag [Presence] in Tissue by Immune stain | |
10503-1 | | Lysozyme Ag [Presence] in Tissue by Immune stain | |
10504-9 | | Myelin basic protein Ag [Presence] in Tissue by Immune stain | |
10505-6 | | Myoglobin Ag [Presence] in Tissue by Immune stain | |
10506-4 | | Peanut agglutinin Ag [Presence] in Tissue by Immune stain | |
10507-2 | | Prolactin Ag [Presence] in Tissue by Immune stain | |
10508-0 | | Prostate specific Ag [Presence] in Tissue by Immune stain | |
10509-8 | | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain | |
1051-2 | | Hemolytic disease of newborn screen [Interpretation] in Blood | |
10510-6 | | S-100 Ag [Presence] in Tissue by Immune stain | |
10511-4 | | Serotonin Ag [Presence] in Tissue by Immune stain | |
10512-2 | | Somatostatin Ag [Presence] in Tissue by Immune stain | |
10513-0 | | Somatotropin Ag [Presence] in Tissue by Immune stain | |
10514-8 | | Synaptophysin Ag [Presence] in Tissue by Immune stain | |
10515-5 | | Thyroglobulin Ag [Presence] in Tissue by Immune stain | |
10516-3 | | Thyrotropin Ag [Presence] in Tissue by Immune stain | |
10517-1 | | Trypsin Ag [Presence] in Tissue by Immune stain | |
10518-9 | | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain | |
10519-7 | | Vimentin Ag [Presence] in Tissue by Immune stain | |
1052-0 | | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit | |
10520-5 | | Coagulation factor VI Ag [Presence] in Tissue by Immune stain | |
10521-3 | | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain | |
10522-1 | | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain | |
10523-9 | | Fibrinogen Ag [Presence] in Tissue by Immune stain | |
10524-7 | | Microscopic observation [Identifier] in Cervix by Cyto stain | |
10525-4 | | Microscopic observation [Identifier] in Specimen by Cyto stain | |
10526-2 | | Microscopic observation [Identifier] in Sputum by Cyto stain | |
10527-0 | | Microscopic observation [Identifier] in Tissue by Cyto stain | |
10528-8 | | Acetophenazine [Mass/volume] in Serum or Plasma | |
10529-6 | | Amoxapine metabolite [Mass/volume] in Serum or Plasma | |
1053-8 | | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor | |
10530-4 | | Aprobarbital [Mass/volume] in Serum or Plasma | |
10531-2 | | Bretylium [Mass/volume] in Serum or Plasma | |
10532-0 | | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma | |
10533-8 | | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma | |
10534-6 | | Diazoxide [Mass/volume] in Serum or Plasma | |
10535-3 | | Digoxin [Mass/volume] in Serum or Plasma | |
10536-1 | | Dipyridamole [Mass/volume] in Serum or Plasma | |
10537-9 | | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | |
10538-7 | | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | |
10539-5 | | glipiZIDE [Mass/volume] in Serum or Plasma | |
1054-6 | | Deprecated I (intermediate) subtype [Presence] in srum | |
10540-3 | | glyBURIDE [Mass/volume] in Serum or Plasma | |
10541-1 | | Mepivacaine [Mass/volume] in Serum or Plasma | |
10542-9 | | Metharbital [Mass/volume] in Serum or Plasma | |
10543-7 | | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma | |
10544-5 | | Normeperidine [Presence] in Serum or Plasma | |
10545-2 | | Normephenytoin [Mass/volume] in Serum or Plasma | |
10546-0 | | Normethsuximide [Mass/volume] in Serum or Plasma | |
10547-8 | | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma | |
10548-6 | | Phenytoin Free/Phenytoin.total in Serum or Plasma | |
10549-4 | | Pirmenol [Mass/volume] in Serum or Plasma | |
1055-3 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit | |
10550-2 | | Deprecated Temazepam [Mass/volume] in Serum or Plasma | |
10551-0 | | Triamterene [Mass/volume] in Serum or Plasma | |
10552-8 | | Tricyclic antidepressants [Mass/volume] in Serum or Plasma | |
10553-6 | | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid | |
10554-4 | | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma | |
10555-1 | | Acrosin [Entitic Catalytic Activity] in Spermatozoa | |
10556-9 | | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma | |
10557-7 | | Adenosine triphosphate [Moles/volume] in Semen | |
10558-5 | | Albumin [Moles/volume] in Semen | |
10559-3 | | Deprecated Calcium [Molecules/volume] in Semen | |
1056-1 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor | |
10560-1 | | Carcinoembryonic Ag [Units/volume] in Semen | |
10561-9 | | Carnitine [Moles/volume] in Semen | |
10562-7 | | Cells [#/volume] in Cervical mucus | |
10563-5 | | Cells other than spermatozoa [#/volume] in Semen | |
10564-3 | | Cervical mucus [Volume] | |
10565-0 | | Choriogonadotropin [Units/volume] in Semen | |
10566-8 | | Deprecated Choriogonadotropin [Molecules/volume] in Semen | |
10567-6 | | Citrate [Moles/volume] in Semen | |
10568-4 | | Clarity of Semen | |
10569-2 | | Color of Semen | |
1057-9 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells | |
10570-0 | | Consistency of Cervical mucus | |
10571-8 | | Deprecated Consistency of Semen | |
10572-6 | | Deprecated Duration^post ejaculation | |
10573-4 | | Ferning [Type] in Cervical mucus | |
10574-2 | | Fructose [Moles/volume] in Semen | |
10575-9 | | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen | |
10576-7 | | Germ cells.immature [#/volume] in Semen | |
10577-5 | | Glucosidase [Enzymatic activity/volume] in Seminal plasma | |
10578-3 | | Glycerophosphocholine [Moles/volume] in Seminal plasma | |
10579-1 | | Leukocytes [#/volume] in Semen | |
1058-7 | | I Ab [Presence] in Serum or Plasma from Blood product unit | |
10580-9 | | Liquefaction [Time] in Semen | |
10581-7 | | Deprecated Number of entities [#] in Spermatozoa | |
10582-5 | | pH of Cervical mucus | |
10583-3 | | Prostaglandin F1 alpha [Moles/volume] in Semen | |
10584-1 | | Deprecated Protein [Mass/volume] in Semen | |
10585-8 | | Round cells [#/volume] in Semen | |
10586-6 | | Deprecated Volume of Semen | |
10587-4 | | Sexual abstinence duration | |
10588-2 | | Spermatogonia [#/volume] in Semen | |
10589-0 | | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) | |
1059-5 | | I Ab [Presence] in Serum or Plasma from Donor | |
10590-8 | | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) | |
10591-6 | | Primary Spermatocytes [#/volume] in Semen | |
10592-4 | | Secondary Spermatocytes [#/volume] in Semen | |
10593-2 | | Spermatozoa Pyriform Head/100 spermatozoa in Semen | |
10594-0 | | Spermatozoa Tapering Head/100 spermatozoa in Semen | |
10595-7 | | Deprecated Spermatozoa [#/volume] in Semen | |
10596-5 | | Deprecated Spermatozoa Ab in cervical mucosa | |
10597-3 | | Deprecated Spermatozoa Ab in semen | |
10598-1 | | Deprecated Spermatozoa Ab in serum | |
10599-9 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test | |
106-5 | | Ceforanide [Susceptibility] by Serum bactericidal titer | |
1060-3 | | I Ab [Presence] in Serum or Plasma | |
10600-5 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa | |
10601-3 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus | |
10602-1 | | Spermatozoa Abnormal Head/100 spermatozoa in Semen | |
10603-9 | | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen | |
10604-7 | | Spermatozoa Abnormal Tail/100 spermatozoa in Semen | |
10605-4 | | Spermatozoa Agglutinated/100 spermatozoa in Semen | |
10606-2 | | Spermatozoa Amorphous Head/100 spermatozoa in Semen | |
10607-0 | | Spermatozoa Coiled Tail/100 spermatozoa in Semen | |
10608-8 | | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen | |
10609-6 | | Spermatozoa Duplicate Head/100 spermatozoa in Semen | |
1061-1 | | Deprecated I NOS Ab [Presence] in Serum or Plasma from Blood product unit | |
10610-4 | | Spermatozoa Duplicate Tail/100 spermatozoa in Semen | |
10611-2 | | Spermatozoa Immotile/100 spermatozoa in Semen | |
10612-0 | | Spermatozoa Large Oval Head/100 spermatozoa in Semen | |
10613-8 | | Spermatozoa Viable/100 spermatozoa in Semen | |
10614-6 | | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead | |
10615-3 | | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
10616-1 | | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead | |
10617-9 | | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
10618-7 | | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead | |
10619-5 | | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
1062-9 | | Deprecated I NOS Ab [Presence] in Serum or Plasma from Donor | |
10620-3 | | Spermatozoa Nonprogressive/100 spermatozoa in Semen | |
10621-1 | | Spermatozoa Normal Head/100 spermatozoa in Semen | |
10622-9 | | Spermatozoa Normal/100 spermatozoa in Semen | |
10623-7 | | Spermatozoa Pin Head/100 spermatozoa in Semen | |
10624-5 | | Spermatozoa Rapid/100 spermatozoa in Semen | |
10625-2 | | Spermatozoa Round Head/100 spermatozoa in Semen | |
10626-0 | | Spermatozoa Slow/100 spermatozoa in Semen | |
10627-8 | | Spermatozoa Small Oval Head/100 spermatozoa in Semen | |
10628-6 | | Spermatozoa Tail Swelling/100 spermatozoa in Semen | |
10629-4 | | Spermatozoa Vacuolated Head/100 spermatozoa in Semen | |
1063-7 | | Deprecated I NOS Ab [Presence] in Serum or Plasma | |
10630-2 | | Spinnbarkeit [Length] in Cervical mucus | |
10631-0 | | Testosterone [Moles/volume] in Semen | |
10632-8 | | Time until next menstrual period | |
10633-6 | | Zinc [Moles/volume] in Semen | |
10634-4 | | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma | |
10635-1 | | Acanthamoeba sp identified in Eye by Organism specific culture | |
10636-9 | | Acanthamoeba sp identified in Eye by Wet preparation | |
10637-7 | | Microscopic observation [Identifier] in Tissue by Night blue stain | |
10638-5 | | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture | |
10639-3 | | Thermophilic Actinomycetes identified in Specimen by Organism specific culture | |
1064-5 | | Deprecated I NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
10640-1 | | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy | |
10641-9 | | Amoeba identified in Aspirate by Immune stain | |
10642-7 | | Amoeba identified in Aspirate by Wet preparation | |
10643-5 | | Amoeba identified in Stool by Organism specific culture | |
10644-3 | | Arthropod identified in Specimen | |
10645-0 | | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence | |
10646-8 | | Astrovirus [Identifier] in Stool by Electron microscopy | |
10647-6 | | Babesia sp identified in Blood by Thick film | |
10648-4 | | Babesia sp identified in Blood by Thin film | |
10649-2 | | Calicivirus [Identifier] in Stool by Electron microscopy | |
1065-2 | | Deprecated I NOS Ag [Presence] on Red Blood Cells from Donor | |
10650-0 | | Candida sp DNA [Presence] in Blood by Probe with amplification | |
10651-8 | | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial | |
10652-6 | | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification | |
10653-4 | | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) | |
10654-2 | | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) | |
10655-9 | | Coccidia identified in Duodenal fluid by Acid fast stain | |
10656-7 | | Coccidia identified in Stool by Acid fast stain | |
10657-5 | | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence | |
10658-3 | | Cyanobacterium identified in Water by Light microscopy | |
10659-1 | | Cyclospora sp identified in Stool by Acid fast stain | |
1066-0 | | Deprecated I NOS Ag [Presence] on Red Blood Cells | |
10660-9 | | Cytomegalovirus Ag [Presence] in Tissue by Immune stain | |
10661-7 | | Dinoflagellate identified in Water by Light microscopy | |
10662-5 | | Filaria identified in Blood by Concentration | |
10663-3 | | Filaria identified in Blood by Thick film | |
10664-1 | | Filaria identified in Blood by Thin film | |
10665-8 | | Fungus colony count [#/volume] in Specimen by Environmental culture | |
10666-6 | | Fungus identified in Tissue by Fontana-Masson stain | |
10667-4 | | Fungus identified in Specimen by Animal inoculation | |
10668-2 | | Fungus identified in Specimen by Environmental culture | |
10669-0 | | Fungus identified in Specimen by Sticky tape for environmental fungus | |
1067-8 | | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | |
10670-8 | | Giardia lamblia [Presence] in Stool by Organism specific culture | |
10671-6 | | Helminth identified in Specimen | |
10672-4 | | Helminth+Arthropod identified in Specimen | |
10673-2 | | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain | |
10674-0 | | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain | |
10675-7 | | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain | |
10676-5 | | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | |
10677-3 | | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain | |
10678-1 | | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain | |
10679-9 | | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain | |
1068-6 | | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor | |
10680-7 | | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy | |
10681-5 | | Herpes simplex virus identified in Tissue by Electron microscopy | |
10682-3 | | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification | |
10683-1 | | Hydatid cyst identified in Aspirate by Immune stain | |
10684-9 | | Hydatid cyst identified in Liver by Wet preparation | |
10685-6 | | Hydatid cyst identified in Lung tissue by Wet preparation | |
10686-4 | | Leishmania sp identified in Tissue by Giemsa stain | |
10687-2 | | Leishmania sp identified in Tissue by Organism specific culture | |
10688-0 | | Microscopic observation [Identifier] in Hair by KOH preparation | |
10689-8 | | Microscopic observation [Identifier] in Nail by KOH preparation | |
1069-4 | | Jk sup(a) Ab [Presence] in Serum or Plasma | |
10690-6 | | Microsporidia identified in Duodenal fluid by Trichrome stain modified | |
10691-4 | | Mushroom.toxic identified by Inspection | |
10692-2 | | Mushroom.toxic identified in Food by Light microscopy | |
10693-0 | | Mushroom.toxic identified in Vomitus by Light microscopy | |
10694-8 | | Naegleria sp identified in Tissue by Organism specific culture | |
10695-5 | | Naegleria sp identified in Tissue by Wet preparation | |
10696-3 | | Norovirus [Identifier] in Stool by Electron microscopy | |
10697-1 | | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | |
10698-9 | | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | |
10699-7 | | Onchocerca sp identified in Tissue by Wet preparation | |
107-3 | | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | |
1070-2 | | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | |
10700-3 | | Orthopoxvirus [Identifier] in Skin by Electron microscopy | |
10701-1 | | Ova and parasites identified in Stool by Concentration | |
10702-9 | | Ova and parasites identified in Stool by Immune stain | |
10703-7 | | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain | |
10704-5 | | Ova and parasites identified in Stool by Light microscopy | |
10705-2 | | Human papilloma virus Ag [Presence] in Tissue by Immune stain | |
10706-0 | | Picornavirus [Identifier] in Stool by Electron microscopy | |
10707-8 | | Toxic Plant identified in Plant specimen by Inspection | |
10708-6 | | Toxic Plant identified in Vomitus by Light microscopy | |
10709-4 | | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence | |
1071-0 | | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor | |
10710-2 | | Plasmodium sp identified in Blood by Thin film | |
10711-0 | | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence | |
10712-8 | | Pneumocystis sp identified in Lung tissue | |
10713-6 | | Prototheca identified in Specimen by Culture | |
10714-4 | | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy | |
10715-1 | | Schistosoma sp identified in Urine sediment by Light microscopy | |
10716-9 | | Schistosoma sp identified in Specimen by Organism specific culture | |
10717-7 | | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination | |
10718-5 | | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay | |
10719-3 | | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot | |
1072-8 | | Jk sup(a) Ag [Presence] on Red Blood Cells | |
10720-1 | | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) | |
10721-9 | | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) | |
10722-7 | | Torovirus [Identifier] in Stool by Electron microscopy | |
10723-5 | | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay | |
10724-3 | | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay | |
10725-0 | | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification | |
10726-8 | | Toxoplasma gondii [Presence] in Tissue by Giemsa stain | |
10727-6 | | Toxoplasma gondii identified in Tissue | |
10728-4 | | Trichomonas sp identified in Genital specimen by Organism specific culture | |
10729-2 | | Trypanosoma sp identified in Blood by Light microscopy | |
1073-6 | | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | |
10730-0 | | Trypanosoma sp identified in Blood by Organism specific culture | |
10731-8 | | Trypanosoma sp identified in Blood by Thick film | |
10732-6 | | Trypanosoma sp identified in Blood by Thin film | |
10733-4 | | Trypanosoma sp identified in Blood by Wet preparation | |
10734-2 | | Varicella zoster virus identified in Skin by Electron microscopy | |
10735-9 | | Viral sequencing [Identifier] in Serum by Sequencing | |
10736-7 | | Virus identified in Cerebral spinal fluid by Electron microscopy | |
10737-5 | | Virus identified in Stool by Electron microscopy | |
10738-3 | | Virus identified in Tissue by Electron microscopy | |
10739-1 | | Virus identified in Specimen by Electron microscopy | |
1074-4 | | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor | |
10740-9 | | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain | |
10741-7 | | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain | |
10742-5 | | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified | |
10743-3 | | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain | |
10744-1 | | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain | |
10745-8 | | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain | |
10746-6 | | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain | |
10747-4 | | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain | |
10748-2 | | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain | |
10749-0 | | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain | |
1075-1 | | Jk sup(b) Ab [Presence] in Serum or Plasma | |
10750-8 | | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson | |
10751-6 | | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain | |
10752-4 | | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain | |
10753-2 | | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain | |
10754-0 | | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain | |
10755-7 | | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott | |
10756-5 | | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain | |
10757-3 | | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald | |
10758-1 | | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain | |
10759-9 | | Iron.microscopic observation [Identifier] in Sputum by Gomori stain | |
1076-9 | | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | |
10760-7 | | Iron.microscopic observation [Identifier] in Tissue by Gomori stain | |
10761-5 | | Iron.microscopic observation [Identifier] in Tissue by Other stain | |
10762-3 | | Microscopic observation [Identifier] in Blood by Hemosiderin stain | |
10763-1 | | Microscopic observation [Identifier] in Body fluid by Sudan black stain | |
10764-9 | | Microscopic observation [Identifier] in Sputum by Silver stain | |
10765-6 | | Microscopic observation [Identifier] in Tissue by Acetate esterase stain | |
10766-4 | | Microscopic observation [Identifier] in Tissue by Alcian blue stain | |
10767-2 | | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated | |
10768-0 | | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff | |
10769-8 | | Microscopic observation [Identifier] in Tissue by Alizarin red S stain | |
1077-7 | | Jk sup(b) Ag [Presence] on Red Blood Cells from Donor | |
10770-6 | | Microscopic observation [Identifier] in Tissue by Argentaffin stain | |
10771-4 | | Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain | |
10772-2 | | Microscopic observation [Identifier] in Tissue by Azure-eosin stain | |
10773-0 | | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain | |
10774-8 | | Microscopic observation [Identifier] in Tissue by Bielschowsky stain | |
10775-5 | | Microscopic observation [Identifier] in Tissue by Bleach stain | |
10776-3 | | Microscopic observation [Identifier] in Tissue by Bodian stain | |
10777-1 | | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain | |
10778-9 | | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain | |
10779-7 | | Microscopic observation [Identifier] in Tissue by Carmine stain.Best | |
1078-5 | | Jk sup(b) Ag [Presence] on Red Blood Cells | |
10780-5 | | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain | |
10781-3 | | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain | |
10782-1 | | Microscopic observation [Identifier] in Tissue by Congo red stain | |
10783-9 | | Microscopic observation [Identifier] in Tissue by Crystal violet stain | |
10784-7 | | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific | |
10785-4 | | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain | |
10786-2 | | Deprecated Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron | |
10787-0 | | Microscopic observation [Identifier] in Tissue by Gridley stain | |
10788-8 | | Microscopic observation [Identifier] in Tissue by Hansel stain | |
10789-6 | | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain | |
1079-3 | | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | |
10790-4 | | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain | |
10791-2 | | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain | |
10792-0 | | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones | |
10793-8 | | Microscopic observation [Identifier] in Tissue by Methyl green stain | |
10794-6 | | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain | |
10795-3 | | Microscopic observation [Identifier] in Tissue by Methyl violet stain | |
10796-1 | | Microscopic observation [Identifier] in Tissue by Mucicarmine stain | |
10797-9 | | Microscopic observation [Identifier] in Tissue by Neutral red stain | |
10798-7 | | Microscopic observation [Identifier] in Tissue by Oil red O stain | |
10799-5 | | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat | |
108-1 | | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) | |
1080-1 | | Js sup(a) Ab [Presence] in Serum or Plasma from Donor | |
10800-1 | | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion | |
10801-9 | | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain | |
10802-7 | | Microscopic observation [Identifier] in Tissue by Prussian blue stain | |
10803-5 | | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain | |
10804-3 | | Microscopic observation [Identifier] in Tissue by Reticulin stain | |
10805-0 | | Microscopic observation [Identifier] in Tissue by Safranin stain | |
10806-8 | | Microscopic observation [Identifier] in Tissue by Schmorl stain | |
10807-6 | | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain | |
10808-4 | | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle | |
10809-2 | | Microscopic observation [Identifier] in Tissue by Silver nitrate stain | |
1081-9 | | Js sup(a) Ab [Presence] in Serum or Plasma | |
10810-0 | | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson | |
10811-8 | | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius | |
10812-6 | | Microscopic observation [Identifier] in Tissue by Steiner stain | |
10813-4 | | Microscopic observation [Identifier] in Tissue by Sudan black stain | |
10814-2 | | Microscopic observation [Identifier] in Tissue by Supravital stain | |
10815-9 | | Microscopic observation [Identifier] in Tissue by Tetrachrome stain | |
10816-7 | | Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain | |
10817-5 | | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley | |
10818-3 | | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified | |
10819-1 | | Microscopic observation [Identifier] in Tissue by Wade stain | |
1082-7 | | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | |
10820-9 | | Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain | |
10821-7 | | Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain | |
10822-5 | | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer | |
10823-3 | | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale | |
10824-1 | | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain | |
10825-8 | | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain | |
10826-6 | | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain | |
10827-4 | | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain | |
10828-2 | | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain | |
10829-0 | | Silicon [Mass/volume] in Serum or Plasma | |